Moderna Partners with OpenAI to Revolutionize mRNA Medicine

Both our companies have shared values and are research-driven organizations pushing the boundaries of technology to drive transformation
Moderna, Inc. and OpenAI have announced a groundbreaking collaboration aimed at harnessing the transformative power of artificial intelligence (AI) in healthcare and business. This collaboration marks a significant step forward in leveraging AI technology to advance the development and delivery of mRNA medicines, paving the way for revolutionary advancements in healthcare. A Visionary Collaboration for AI Innovation Moderna, renowned for its digital-first approach and early adoption of machine learning, joins forces with OpenAI, a leader in AI research and development. With a shared vision of AI's potential to reshape the future of healthcare, the collaboration is poised to drive innovation and accelerate the delivery of life-changing mRNA medicines. Stéphane Bancel, CEO of Moder
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Research? Book here >

Picture of Anshika Mathews
Anshika Mathews
Anshika is the Senior Content Strategist for AIM Research. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.